NCT02704572View on ClinicalTrials.gov

Optimal Timing of Zoster Vaccine After Zoster Illness

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Shingles
Interventions
BIOLOGICAL

Zostavax

Zostavax will be administrated by subcutaneous injection.

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02704572 - Optimal Timing of Zoster Vaccine After Zoster Illness | Biotech Hunter | Biotech Hunter